---
title: "TSHA: TSHA-102 trials completed dosing; topline data and FDA feedback expected in 1H 2027"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295573802.md"
description: "Dosing completed in pivotal and safety trials for TSHA-102 in Rett syndrome, with topline data and FDA feedback expected in 1H 2027. Financials show increased R&D and G&A expenses, a net loss of $46.6M, and a cash runway into 2H 2028 following a $230M offering.Original document: Taysha Gene Therapies, Inc. [TSHA] SEC 8-K Current Report — Aug. 11 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-11T20:08:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295573802.md)
  - [en](https://longbridge.com/en/news/295573802.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295573802.md)
generator: "portal-rs"
---

# TSHA: TSHA-102 trials completed dosing; topline data and FDA feedback expected in 1H 2027

Dosing completed in pivotal and safety trials for TSHA-102 in Rett syndrome, with topline data and FDA feedback expected in 1H 2027. Financials show increased R&D and G&A expenses, a net loss of $46.6M, and a cash runway into 2H 2028 following a $230M offering.

Original document: Taysha Gene Therapies, Inc. \[TSHA\] SEC 8-K Current Report — Aug. 11 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [TSHA.US](https://longbridge.com/en/quote/TSHA.US.md)

## Related News & Research

- [TSHA: TSHA-102 showed durable, accumulating functional gains and strong safety in Rett syndrome trials](https://longbridge.com/en/news/290435744.md)
- [Taysha Gene Therapies posts corporate deck highlighting TSHA-102 gene therapy program for Rett syndrome](https://longbridge.com/en/news/293788160.md)
- [Filevine launches 90-day free trial for LOIS legal AI system](https://longbridge.com/en/news/296383497.md)
- [Apple Is The Most Underappreciated AI Mega-Cap, Analyst Says](https://longbridge.com/en/news/296382210.md)
- [AI Has More Winners Than Ever – Here’s the Catch](https://longbridge.com/en/news/296384763.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**